TY - JOUR
T1 - Colonoscopy as a screening test for colorectal cancer in average-risk individuals
AU - Swaroop, Vege Santhi
AU - Larson, Mark V.
N1 - Copyright:
Copyright 2018 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - Screening for colorectal cancer has become the standard of care and is currently recommended by most major health organizations, including the American Cancer Society. Randomized controlled trials using fecal occult blood testing as the screening strategy have shown a reduction in mortality due to colorectal cancer. However, colorectal cancer differs from other cancers in that a variety of screening tests have been approved and recommended by experts. The advantages and disadvantages of different screening tests have been the subject of intense debate. Colonoscopy has theoretical advantages over other screening tests, including direct visualization of the entire colon and, more importantly, removal of precancerous adenomatous lesions. This review discusses the advantages and disadvantages of colonoscopy as a screening test for colorectal cancer with regard to efficacy, cost-effectiveness, and patient compliance.
AB - Screening for colorectal cancer has become the standard of care and is currently recommended by most major health organizations, including the American Cancer Society. Randomized controlled trials using fecal occult blood testing as the screening strategy have shown a reduction in mortality due to colorectal cancer. However, colorectal cancer differs from other cancers in that a variety of screening tests have been approved and recommended by experts. The advantages and disadvantages of different screening tests have been the subject of intense debate. Colonoscopy has theoretical advantages over other screening tests, including direct visualization of the entire colon and, more importantly, removal of precancerous adenomatous lesions. This review discusses the advantages and disadvantages of colonoscopy as a screening test for colorectal cancer with regard to efficacy, cost-effectiveness, and patient compliance.
UR - http://www.scopus.com/inward/record.url?scp=0036725188&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036725188&partnerID=8YFLogxK
U2 - 10.4065/77.9.951
DO - 10.4065/77.9.951
M3 - Article
C2 - 12233928
AN - SCOPUS:0036725188
SN - 0025-6196
VL - 77
SP - 951
EP - 956
JO - Mayo Clinic proceedings
JF - Mayo Clinic proceedings
IS - 9
M1 - 62262
ER -